Article
Tumor clone dynamics in lethal prostate cancer.
Science translational medicine - 17 Sept 2014
Carreira Suzanne, Romanel Alessandro, Goodall Jane, Grist Emily, Ferraldeschi Roberta, Miranda Susana, Prandi Davide, Lorente David, Frenel Jean-Sebastien, Pezaro Carmel, Omlin Aurelius, Rodrigues Daniel Nava, Flohr Penelope, Tunariu Nina, S de Bono Johann, Demichelis Francesca, Attard Gerhardt
Abstract excerpt
It is unclear whether a single clone metastasizes and remains dominant over the course of lethal prostate cancer. We describe the clonal architectural heterogeneity at different stages of disease progression by sequencing serial plasma and tumor samples from 16 ERG-positive patients. By characterizing the clonality of commonly occurring deletions at 21q22, 8p21, and 10q23, we identified multiple independent...
Topics
- Adult
- Aged
- Aged, 80 and over
- Chromosome Deletion
- Clone Cells
- DNA Copy Number Variations
- Glucocorticoids
- Humans
- Male
- Middle Aged
